PE-VC background remains critical for pre-revenue biotech IPOs, says HKEX executive

Christina Bao, managing director and co-head of sales & marketing at the Hong Kong Exchanges and Clearing (HKEX)

Printed by Unregistered user on Sun, 24 Aug 2025 12:15:33 GMT